Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

High eosinophil count in rectal biopsy samples, high serum 25(OH)D concentration, haemoglobin concentration of greater than or equal to 10 g/dL, and remission by week 4 were also associated with a lack of escalaton to anti-TNFα (n = 232; Table 4).

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In the PROTECT Study, patients were recruited from 29 North American centers between July 2012 and April 2015.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

A comparison of Bayesian and frequentist approaches to incorporating clinical and biological information for the prediction of response to standardized pediatric colitis therapy

Study design awaiting verification · PLOS ONE · 2024

Original publication title

A comparison of Bayesian and frequentist approaches to incorporating clinical and biological information for the prediction of response to standardized pediatric colitis therapy

Zhu Wang; Jia Nie; Xing Song; Lee A. Denson; Jeffrey S. Hyams

© 2024 Wang et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

BLR and BART models had intuitive interpretation on interval estimation, better precision in estimating the AUC and can be alternatives for predicting clinical outcomes in pediatric patients with UC. BART model can estimate nonlinear nonparametric association.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The prospective cohort study PROTECT is the largest study in pediatric ulcerative colitis (UC) with standardized treatments, providing valuable data for predicting clinical outcomes. PROTECT and previous studies have identified characteristics associated with clinical outcomes. In this study, we aimed to compare predictive modeling between Bayesian analysis including machine learning and frequentist analysis.

Source: Background

Abstract: What methods does the paper describe?

The key outcomes for this analysis were week 4, 12 and 52 corticosteroid (CS)-free remission following standardized treatment from diagnosis. We developed predictive modeling with multivariable Bayesian logistic regression (BLR), Bayesian additive regression trees (BART) and frequentist logistic regression (FLR). The effect estimate of each risk factor was estimated and compared between the BLR and FLR models. The predictive performance of the models was assessed including area under curve (AUC) of the receiver operating characteristic (ROC) curve. Ten-fold cross-validation was performed for internal validation of the models.

The estimation contained 95% credible (or confidence) interval (CI).

Source: Methods

Abstract: Results

The statistically significant associations between the risk factors and early or late outcomes were consistent between all BLR and FLR models. The model performance was similar while BLR and BART models had narrower credible intervals of AUCs. To predict week 4 CS-free remission, the BLR model had AUC of 0.69 (95% CI 0.67 to 0.70), the BART model had AUC of 0.70 (0.67 to 0.72), and the FLR had AUC of 0.70 (0.65 to 0.76). To predict week 12 CS-free remission, the BLR model had AUC of 0.78 (0.77 to 0.79), the BART model had AUC of 0.78 (0.77 to 0.79), and the FLR model had AUC of 0.79 (0.74 to 0.83).

To predict week 52 CS-free remission, the BLR model had AUC of 0.69 (0.68 to 0.70), the BART model had AUC of 0.69 (0.67 to 0.70), and the FLR model had AUC of 0.69 (0.64 to 0.74). The BART model identified nonlinear associations.

Source: Results

Abstract: Conclusions

BLR and BART models had intuitive interpretation on interval estimation, better precision in estimating the AUC and can be alternatives for predicting clinical outcomes in pediatric patients with UC. BART model can estimate nonlinear nonparametric association.

Source: Conclusions
Authors’ abstract

Background

The prospective cohort study PROTECT is the largest study in pediatric ulcerative colitis (UC) with standardized treatments, providing valuable data for predicting clinical outcomes. PROTECT and previous studies have identified characteristics associated with clinical outcomes. In this study, we aimed to compare predictive modeling between Bayesian analysis including machine learning and frequentist analysis.

Methods

The key outcomes for this analysis were week 4, 12 and 52 corticosteroid (CS)-free remission following standardized treatment from diagnosis. We developed predictive modeling with multivariable Bayesian logistic regression (BLR), Bayesian additive regression trees (BART) and frequentist logistic regression (FLR). The effect estimate of each risk factor was estimated and compared between the BLR and FLR models. The predictive performance of the models was assessed including area under curve (AUC) of the receiver operating characteristic (ROC) curve. Ten-fold cross-validation was performed for internal validation of the models.

The estimation contained 95% credible (or confidence) interval (CI).

Results

The statistically significant associations between the risk factors and early or late outcomes were consistent between all BLR and FLR models. The model performance was similar while BLR and BART models had narrower credible intervals of AUCs. To predict week 4 CS-free remission, the BLR model had AUC of 0.69 (95% CI 0.67 to 0.70), the BART model had AUC of 0.70 (0.67 to 0.72), and the FLR had AUC of 0.70 (0.65 to 0.76). To predict week 12 CS-free remission, the BLR model had AUC of 0.78 (0.77 to 0.79), the BART model had AUC of 0.78 (0.77 to 0.79), and the FLR model had AUC of 0.79 (0.74 to 0.83).

To predict week 52 CS-free remission, the BLR model had AUC of 0.69 (0.68 to 0.70), the BART model had AUC of 0.69 (0.67 to 0.70), and the FLR model had AUC of 0.69 (0.64 to 0.74). The BART model identified nonlinear associations.

Conclusions

BLR and BART models had intuitive interpretation on interval estimation, better precision in estimating the AUC and can be alternatives for predicting clinical outcomes in pediatric patients with UC. BART model can estimate nonlinear nonparametric association.

Publication and source details

Original title: A comparison of Bayesian and frequentist approaches to incorporating clinical and biological information for the prediction of response to standardized pediatric colitis therapy

Zhu Wang; Jia Nie; Xing Song; Lee A. Denson; Jeffrey S. Hyams

PLOS ONE · 2024

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: zwang145@uthsc.edu
© 2024 Wang et al2024Wang et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://dx.doi.org/10.13039/100000062National Institute of Diabetes and Digestive and Kidney Diseases R21DK130006 https://orcid.org/0000-0002-0773-0052 Wang Zhu ZW, XS and JSH obtained funding support for this study provided by the National Institute of Diabetes and Digestive and Kidney Diseases (R21DK130006). The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T12:43:12.622861+00:00

DOI: 10.1371/journal.pone.0295814 · PMC10917270